dc.contributor.author |
Seith, Ferdinand Frederic |
|
dc.contributor.author |
Schwartz, Martin |
|
dc.contributor.author |
Schwenck, Johannes Walter |
|
dc.contributor.author |
Garbe, Claus |
|
dc.contributor.author |
Nikolaou, Konstantin |
|
dc.contributor.author |
Schwenzer, Nina |
|
dc.contributor.author |
Pfannenberg, Christina |
|
dc.contributor.author |
Forschner, Andrea Lydia |
|
dc.contributor.author |
Weide, Benjamin Matthias |
|
dc.contributor.author |
Gückel, Brigitte |
|
dc.contributor.author |
Othman, Ahmed |
|
dc.contributor.author |
La Fougère, Christian Jean |
|
dc.date.accessioned |
2021-01-11T11:09:08Z |
|
dc.date.available |
2021-01-11T11:09:08Z |
|
dc.date.issued |
2020 |
|
dc.identifier.issn |
2051-1426 |
|
dc.identifier.uri |
http://hdl.handle.net/10900/111318 |
|
dc.language.iso |
en |
de_DE |
dc.publisher |
Bmj Publishing Group |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.1136/jitc-2020-000656 |
de_DE |
dc.subject.ddc |
570 |
de_DE |
dc.subject.ddc |
610 |
de_DE |
dc.title |
Is there a link between very early changes of primary and secondary lymphoid organs in(18)F-FDG-PET/MRI and treatment response to checkpoint inhibitor therapy? |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20200929220116_01079 |
|
utue.personen.roh |
Seith, Ferdinand |
|
utue.personen.roh |
Forschner, Andrea |
|
utue.personen.roh |
Weide, Benjamin |
|
utue.personen.roh |
Gueckel, Brigitte |
|
utue.personen.roh |
Schwartz, Martin |
|
utue.personen.roh |
Schwenck, Johannes |
|
utue.personen.roh |
Othman, Ahmed E. |
|
utue.personen.roh |
Fenchel, Matthias |
|
utue.personen.roh |
Garbe, Claus |
|
utue.personen.roh |
Nikolaou, Konstantin |
|
utue.personen.roh |
Schwenzer, Nina |
|
utue.personen.roh |
la Fougere, Christian |
|
utue.personen.roh |
Pfannenberg, Christina |
|
dcterms.isPartOf.ZSTitelID |
Journal For Immunotherapy of Cancer |
de_DE |
dcterms.isPartOf.ZS-Issue |
Article e000656 |
de_DE |
dcterms.isPartOf.ZS-Volume |
8 |
de_DE |
utue.fakultaet |
04 Medizinische Fakultät |
de_DE |